- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development of long-acting ARV’s ; volume:14 ; number:2 ; day:23 ; month:5 ; year:2014 ; pages:1 ; date:5.2014
BMC infectious diseases ; 14, Heft 2 (23.5.2014), 1, 5.2014
- Urheber
-
Boffito, Marta
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-S2-S11
- URN
-
urn:nbn:de:1111-2016030320907
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boffito, Marta
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Creation of a long-acting nanoformulated dolutegravir
Development and biological activity of long-acting recombinant human interferon-α2b
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Untersuchungen über die Entstehung von Long-acting thyroid stimulator (LATS)
Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
Recent progress in advanced biomaterials for long-acting reversible contraception
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Creation of a long-acting nanoformulated dolutegravir
Development and biological activity of long-acting recombinant human interferon-α2b
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Untersuchungen über die Entstehung von Long-acting thyroid stimulator (LATS)
Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
Recent progress in advanced biomaterials for long-acting reversible contraception
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
Long-Acting Reversible Contraception
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Creation of a long-acting nanoformulated dolutegravir
Development and biological activity of long-acting recombinant human interferon-α2b
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Adolescents and Long-Acting Reversible Contraception: Lessons from Mexico
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Untersuchungen über die Entstehung von Long-acting thyroid stimulator (LATS)
Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
Recent progress in advanced biomaterials for long-acting reversible contraception